MercyCare ACO Public Reporting
ACO Name and Location
MercyCare Accountable Care Organization, LLC
701 10th Street SE Cedar Rapids, IA 52403
ACO Primary Contact
Tony Myers, MD
319-398-6474
tmyers@mercycare.org
Organizational Information
ACO Participants
|
ACO Participants
|
ACO Participants in Joint Venture
(Enter Y or N)
|
|
Mercy Medical Center
|
N
|
| MercyCare Management, Inc |
N
|
| Mercy Physician Associates, Inc |
N
|
| Radiation Oncology of Cedar Rapids PC |
N
|
ACO Governing Body
|
Member Last Name
|
Member First Name
|
Title/Position
|
Member's Voting Power - Expressed as a percentage or number
|
Membership Type
|
ACO Participant Legal Business Name/ DBA, If Applicable
|
|
Quinn
|
Timothy
|
CEO
|
1
|
ACO Participant Representative
|
MercyCare Management, Inc.
|
|
VanGenderen
|
Nathan
|
COO/CFO
|
1
|
ACO Participant Representative
|
MercyCare Management, Inc.
|
|
Myers
|
Tony
|
Executive Medical Director
|
1
|
ACO Participant Representative
|
MercyCare Diabetes Center
|
|
Pilcher
|
Fred
|
Medicare Beneficiary
|
1
|
Medicare Beneficiary Representative
|
NA
|
Key Clinical and Administrative Leadership
- ACO Executive: Timothy Quinn, MD
- Medical Director: Tony Myers, MD
- Compliance Officer: Ann Peraud Cooke
- Quality Assurance/Improvement Officer: Jennifer Woods
Associated Committees and Committee Leadership
| Committee Name |
Committee Leader Name and Position |
| ACO Monitoring and Planning Committee |
Tony Myers, Executive Medical Director |
| Physician Leadership Council, Executive Committee |
Vince Reid MD, Chairman |
Type of ACO Participants, or Combinations of Participants, that formed the ACO
- Hospital employing ACO professionals
- ACO professionals in a group practice arrangement
Shared Savings and Losses
Amount of Shared Savings/Losses
- Fourth Agreement Period:
- Performance Year 2022, $1,593,794
- Third Agreement Period:
- Performance Year 2021, $1,639,575
- Second Agreement Period
- Performance Year 2020, $2,470,410
- First Agreement Period
- Performance Year 2019, $897,857
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Shared Savings Distribution
-
- Fourth Agreement Period:
- Performance Year 2022
- Proportion invested in infrastructure: 3%
- Proportion invested in redesigned care processes/resources: 3%
- Proportion of distribution to ACO participants: 94%
- Third Agreement Period:
- Performance Year 2021
- Proportion invested in infrastructure: 3%
- Proportion invested in redesigned care processes/resources: 2%
- Proportion of distribution to ACO participants: 95%
- Second Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 4%
- Proportion invested in redesigned care processes/resources: 1%
- Proportion of distribution to ACO participants: 95%
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 11%
- Proportion invested in redesigned care processes/resources: 2%
- Proportion of distribution to ACO participants: 87%
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Quality Performance Results
2022 Quality Performance Results
ACO Quality Measure Number
|
Measure Name
|
Rate
|
ACO Mean
|
|
ACO-001(Lower rate corresponds to higher quality)
|
Diabetes: Hemoglobin A1c (HbA1c) Poor Control
|
7.57 |
10.71
|
|
ACO-236
|
Controlling High Blood Pressure
|
78.46 |
76.16 |
|
ACO-318
|
Falls: Screening for Future Fall Risk
|
99.21 |
87.83 |
|
ACO-110
|
Preventative Care and Screening: Influenza Immunization
|
85.93 |
77.34 |
|
ACO-226
|
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
|
100 |
79.27 |
|
ACO-113
|
Colorectal Cancer Screening
|
70.65 |
75.32 |
|
ACO-112
|
Breast Cancer Screening
|
78.63 |
78.07 |
|
ACO-134
|
Screening for Depression and Follow-Up Plan
|
35.74 |
76.97 |
|
ACO-438
|
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
|
73.53 |
86.37 |
|
ACO-321
|
CAHPS for MIPS
|
N/A |
N/A |
|
ACO-479 (Lower rate corresponds to higher quality)
|
Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Group
|
0.1407 |
0.1510 |
|
ACO-MCC1 (Lower rate corresponds to higher quality)
|
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)
|
33.32 |
30.97 |
|
ACO-370
|
Depression Remission at Twelve Months
|
15.22 |
16.03 |
Per CMS policy, our ACO does not publicly share or report cell sizes <11 or any combination of information that would allow cell sizes of <11 to be calculated.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.
Payment Rule Waivers
- Skilled Nursing Facility (SNF) 3-day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
- Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
